Life

Roper Technologies Inc. Q3 adjusted earnings Beat Estimates

Jason Sudeikis Returns to Play Joe Biden on ‘Saturday Night Live’

Sudeikis, the “Ted Lasso” star and “S.N.L.” alum, revisited some of the characters and sketch formats he popularized as a cast member on the show.


By Dave Itzkoff

New indoor golf simulator facility in RiNo rolls out the green carpet – The Denver Post

Jackknifed semi-truck closes Interstate 70 eastbound at Eisenhower Tunnel

A jackknifed tractor-trailer shut down Interstate 70’s eastbound lanes Sunday morning at the Eisenhower Tunnel, according to the Colorado Department of Transportation.

The eastbound interstate was closed between mile markers 206 and 213 around 8 a.m. and is expected to reopen around 10:15 a.m., according to CDOT.

The crash happened at mile marker 219. Loveland Pass is open, but eastbound traffic from that route is also being stopped because of the closure.

The interstate experienced some snow Sunday morning, and both traction laws and chain laws for commercial vehicles were in place.

Oil Prices Rise On Tight US Supply

Oil prices rose on Friday, reversing part of Thursday’s losses on expectations that tightness in global oil markets will likely continue.

Benchmark Brent crude futures rose 42 cents, or half a percent, to $85.03 a barrel, while U.S. West Texas Intermediate (WTI) crude futures were up 34 cents, or 0.4 percent, at $82.84.

While weaker natural gas and coal prices took away some of the support for the oil market, the tightness in the oil market persists amid lower inventories.

A supply report from the U.S. Energy Information Administration (EIA) showed crude and fuel inventories tightened, with crude inventories at the Cushing storage hub falling to 31.2 million barrels, their lowest level since October 2018, despite refinery crude runs having fallen in the week to October 15.

A Bloomberg analysis explains that stockpiles at the Cushing, Okla., crude oil storage hub – the biggest in the U.S. – are quickly approaching critically low levels, which could push crude prices above current multiyear highs.

What to Cook This Week

Pile Gabrielle Hamilton’s home-fried oysters with tartar sauce onto a split baguette.

By Sam Sifton

RIL net surges 43% on oil products demand

Telecom unit Jio sees profit jump 24%

Reliance Industries Ltd., India’s most valuable company, reported second-quarter profit that jumped 43% to exceed market expectations, as higher demand for oil products boosted its mainstay oil-to-chemicals business.

The conglomerate, led by billionaire Mukesh Ambani, said consolidated profit rose to ₹136.80 billion in the quarter ended September 30, from ₹95.67 billion a year earlier.

Analysts, on average, had expected a profit of ₹134.65 billion, according to Refinitiv data.

Revenue from the oil-to-chemicals unit, home to both its refining and petrochemicals operations, rose 58.1%, benefiting from a sharp recovery in demand across products and higher transportation fuel margin, the company said.

Reliance’s telecom unit Jio reported a 24% rise in profit. Overall revenue from operations rose 50% to ₹1.74 trillion from a year earlier.

How BioNTech went from a little-known biotech company to creating the Covid vaccine

It was Jan. 24, 2020 when BioNTech CEO Uğur Şahin knew that Covid-19 was likely to become a global pandemic. 

Though it was over a month and a half before the World Health Organization officially declared a pandemic, Sahin met with his wife, BioNTech's co-founder and chief medical officer Özlem Türeci. Together, they agreed to redirect most of the company's resources to developing a vaccine. 

"He approached me and explained his thoughts and his his fears," Türeci said. "And it was immediately clear to both of us that the technology we had, and which we had already clinically developed, that could help to ensure a rapid response."

Up until that point, BioNTech was primarily focused on developing novel cancer treatments. The company was little-known internationally. But the founders were confident in the potential of their mRNA technology, which they knew could trigger a powerful immune response. BioNTech knew that to successfully produce, test and manufacture a Covid vaccine on a global scale, it would need a bigger partner. The company already had a relationship with Pfizer, having worked with them since 2018 to develop an mRNA-based flu vaccine, which is in clinical trials. So, BioNTech turned to them.

The companies succeeded. In August, the Pfizer-BioNTech vaccine became the first to gain full FDA approval.

Watch the video to learn about the rise of BioNTech.

Roper Technologies Inc. Q3 adjusted earnings Beat Estimates

Roper Technologies Inc. (ROP) revealed earnings for its third quarter that increased from the same period last year.

The company’s bottom line came in at $289.5 million, or $2.71 per share. This compares with $234.4 million, or $2.21 per share, in last year’s third quarter.

Analysts had expected the company to earn $3.83 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.

The company’s revenue for the quarter rose 21.7% to $1.46 billion from $1.20 billion last year.

Roper Technologies Inc. earnings at a glance:

-EPS (Q3): $3.91 vs. $3.17 last year.
-Analysts Estimate: $3.83
-Revenue (Q3): $1.46 Bln vs. $1.20 Bln last year.

-Guidance:
Next quarter EPS guidance: $3.62 – $3.66
Full year EPS guidance: $14.08 – $14.12